GP2 Cohort Dashboard Now Includes New Ancestry CategoriesLearn More
The updated GP2 Cohort dashboard now includes additional ancestry information across cohort samples that have already been processed and shared with the AMP PD…
Expanded Data Available on GP2’s Updated Cohort DashboardLearn More
The new cohort dashboard provides a real-time look at each cohort within the GP2 network, including location data, number of samples for genotyping, and an anc…
Explore the Monogenic PortalLearn More
The Monogenic Portal gives researchers from around the globe a platform for sharing samples and key insights. Insights are focused on the studying early-onset …
GP2 Announces First Data ReleaseLearn More
GP2 is excited to announce, in collaboration with AMP® PD, our first data release. It consists of 4,908 participants from multiple cohorts.
GP2 Launches Interactive DashboardLearn More
Explore this tool to see our progress collecting diverse cohorts from around the world (updated quarterly).
First-of-its-Kind DNA Biobank Opens in PeruLearn More
ASAP, through GP2 and in partnership with LARGE-PD and the MJFF, celebrated a shared milestone with the inauguration of the DNA Biobank at the Instituto Nacion…
Researching Parkinson’s disease genetics on a global scaleLearn More
This Movement Disorders article explores GP2's ambitions to facilitate the rapid expansion of our understanding of the genetic architecture of PD, both in term…
Black and African American Connections to PDLearn More
GP2 launched BLAAC PD: Black and African American Connections to Parkinson’s Disease, as part of our commitment to increase representation in research and care…
GP2 OpportunitiesLearn More
Development is an important component of our program; our focus is to provide training and other funding opportunities for the next generation of Parkinson’s d…
Introduction to GP2Learn More
In the first GP2 blog post, Andrew Singleton, NIH Distinguished Investigator and GP2 Lead, introduces the program's aims, values and vision.
Introducing the GP2 Learning PlatformLearn More
Training is central to the GP2 effort. Visit our learning platform for training on topics related to Parkinson’s disease genetics.
GP2-funded PhD StudentshipLearn More
Based at UCL, the PhD will involve collaboration with world leaders in PD genetics across the GP2 network. The application deadline is August 31, 2020.
ASAP Announces Global Parkinson’s Genetics Program to Genotype 150,000 VolunteersLearn More
Global Parkinson's Genetics Program (GP2) will support the ongoing search for new genetic determinants of Parkinson's disease in diverse populations.